Skin cells called mast cells are key players in the inflammation and itchiness that can plague folks with these skin ailments ...

It's still early science -- studies in mice and in human cells -- but researchers are on the trail of an effective n ...

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of Pittsburgh study published today in Science Translational Medicine.

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of Pittsburgh study ...

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of ...

About half of people with "chronic spontaneous urticaria," or CSU, the most common type of chronic hives, experience what ...

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of ...

Diagnosing CSU can be difficult for a few main reasons, including the following: CSU is often misdiagnosed because hives are ...

Benuvia Operations, LLC, a global contract development and manufacturing organization, today announced the company has entered into a licensing agreement with Avernus Pharma, a leading provider and ...

Celltrion's asthma treatment Omlyclo, a biosimilar of Novartis's Xolair, has received Canadian approval for chronic urticaria, rhinosinusitis, and allergic asthma ...

“POLARIX was the first trial to elevate treatment standards for frontline diffuse large B-cell lymphoma in 20 years and we are additionally encouraged by the five-year follow-up results,” said Levi ...

When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.